Private Trust Co. NA cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 22.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,509 shares of the healthcare conglomerate’s stock after selling 2,529 shares during the period. Private Trust Co. NA’s holdings in UnitedHealth Group were worth $4,339,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the company. Outfitter Financial LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Blue Bell Private Wealth Management LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $29,000. Advocacy Wealth Management Services LLC boosted its holdings in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. boosted its holdings in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 30 shares in the last quarter. Finally, Tortoise Investment Management LLC boosted its holdings in UnitedHealth Group by 54.8% in the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 23 shares in the last quarter. 87.48% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts have recently weighed in on the company. BMO Capital Markets increased their price objective on UnitedHealth Group from $510.00 to $600.00 and gave the company a “market perform” rating in a report on Tuesday, April 19th. Oppenheimer increased their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a report on Monday, April 18th. Wells Fargo & Company cut their price target on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a research note on Wednesday, May 25th. Loop Capital assumed coverage on UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $482.00 to $549.00 and gave the stock a “buy” rating in a research note on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $555.73.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. During the same quarter last year, the company earned $5.31 earnings per share. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a yield of 1.35%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date is Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.12%.
In other news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Thursday, May 19th. The stock was sold at an average price of $478.96, for a total value of $1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares in the company, valued at approximately $581,936,400. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Frederick William Mcnabb III acquired 89 shares of the business’s stock in a transaction dated Thursday, May 26th. The stock was purchased at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the completion of the acquisition, the director now owns 11,259 shares in the company, valued at $5,678,138.88. The disclosure for this purchase can be found here. 0.40% of the stock is currently owned by company insiders.
About UnitedHealth Group (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.